ESTER POLLARD, MD
Hematology & Oncology Physician in CORPUS CHRISTI, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ESTER POLLARD, MD filed 5,158 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in CORPUS CHRISTI, Texas, prescribing 88% generic.
- 5K
- Part D claims, 2023
- 88%
- generic prescribing
- $4.6K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ESTER POLLARD, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
5,158 Top 6% higher than 94% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
ESTER POLLARD, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ESTER POLLARD, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Hematology & Oncology Physician compares to other specialties among Texas providers
Hematology & Oncology Physician share within Texas
Hematology & Oncology Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Hematology & Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Hematology & Oncology Physician US NPIs
Specialty board-certified rate — Hematology & Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ESTER POLLARD, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 712 BOOTY ST, CORPUS CHRISTI, TX, 78404, with a listed phone of (361) 882-4101. NPI 1225002843 was issued on 02/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what POLLARD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,158 prescription claims written by this provider, covering 257 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 25.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225002843 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 02/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ESTER POLLARD, MD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ESTER POLLARD, MD. Source: openpaymentsdata.cms.gov.
Total received
$4.6K
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to ESTER POLLARD, MD. To verify ESTER POLLARD, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 5,158 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,949
- Total Day Supply
- 162,772
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $2.3M
- Generic Drug Cost
- $180K
- Opioid Claims
- 1,322 (25.6% rate)
- Antibiotic Claims
- 372
Patient Demographics
- Average Patient Age
- 66.3 years
- Avg HCC Risk Score
- 2.65
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 79, 65-74: 118, 75-84: 49, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ESTER POLLARD, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
885 claims
- Alprazolam 308
Alprazolam
308 claims
- Prednisone 167
Prednisone
167 claims
- Tramadol Hcl 152
Tramadol Hcl
152 claims
- Azithromycin 139
Azithromycin
139 claims
- Gabapentin 115
Gabapentin
115 claims
- Ibuprofen 96
Ibuprofen
96 claims
- Amlodipine Besylate 94
Amlodipine Besylate
94 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 885 |
| Alprazolam | 308 |
| Prednisone | 167 |
| Tramadol Hcl | 152 |
| Azithromycin | 139 |
| Gabapentin | 115 |
| Ibuprofen | 96 |
| Amlodipine Besylate | 94 |
| Fentanyl | 91 |
| Hydromorphone Hcl | 85 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How ESTER POLLARD, MD fits within the Hematology & Oncology Physician landscape nationally.
ESTER POLLARD, MD's 5,158 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as POLLARD.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is ESTER POLLARD, MD's specialty? ▼
How much does ESTER POLLARD, MD prescribe under Medicare Part D? ▼
Where is ESTER POLLARD, MD located? ▼
What is ESTER POLLARD, MD's NPI number? ▼
Does ESTER POLLARD, MD prescribe more brand-name or generic drugs? ▼
Does ESTER POLLARD, MD prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does ESTER POLLARD, MD prescribe most often? ▼
Does ESTER POLLARD, MD accept Medicare? ▼
How can I verify ESTER POLLARD, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology